Experiencia en el manejo de malformaciones linfáticas macroquísticas con alcohol y microquísticas con bleomicina

Authors

  • José Fernando Vallejo Díaz Clínica Centro Médico Imbanaco
  • Max Alberto Bernal Moreno Instituto Nacional de Pediatría
  • Carola Mckinster Instituto Nacional de Pediatria
  • Gerardo Montejo Instituto Nacional de Pediatría

DOI:

https://doi.org/10.53903/01212095.124

Keywords:

Lymphatic diseases, Sclerotherapy, Magnetic resonance imaging

Abstract

Lymphatic malformations are rare slow and low flow abnormalities that occur in 1 of 6,000 to 1 in 16,000 live newborns. Cystic malformations are classified according to their size as macrocystic, microcystic, or mixed. This classification has an impact on treatment and prognosis. Macrocystic lymphatic malformations have a better response to treatment, while microcystic malformations are difficult to treat and frequently recur. The objective of this study is to describe the results obtained in patients with macro and microcystic lymphatic malformations who underwent sclerotherapy using alcohol and Bleomycin, respectively. A descriptive study of patients with lymphatic malformations treated in the Radiology Service of the National Institute of Pediatrics was carried out during the period from 2014 to 2016. Thirty-eight patients were included, 24 with macrocystic, 10 microcystic and 4 mixed lesions. 68% were treated with alcohol and 32% of the patients were treated with Bleomycin. The treatment showed excellent resolution in 5 patients, 25 patients had a lesion size reduction between 50 and 90%, 13% had a poor response, and only 7% had growth despite sclerosing treatment. From the above we conclude that percutaneous treatment is safe, reduces the size of the lesions and there are few reported complications. It could be used as initial treatment before considering surgery.

Downloads

Download data is not yet available.

References

Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations: Part I. J Am Acad Dermatol. 2007;56(3):353-70; quiz 71-4.

Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol. 2005;53(1):35-45

Baskin D, Tander B, Bankaoğlu M. Local bleomycin injection in the treatment of lymphangioma. Eur J Pediatr Surg. 2005;15(6):383-6

Yetiser S, Karaman K. Treatment of lymphangioma of the face with intralesional bleomycin: case discussion and literature review. J Maxillofac Oral Surg. 2011;10(2):152-4.

Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds JL, Hoffer FA, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg. 2010;142(6):795-803.

Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg. 2008;138(4):418-24.

Defnet AM, Bagrodia N, Hernández SL, Gwilliam N, Kandel JJ. Pediatric lymphatic malformations: evolving understanding and therapeutic options. Pediatr Surg Int. 2016;32(5):425-33

Eivazi B, Werner JA. [Extracranial vascular anomalies (hemangiomas and vascular malformations) in children and adolescents--diagnosis, clinic, and therapy]. Laryngorhinootologie. 2014;93 Suppl 1:S185-202

Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: a systematic review. Otolaryngol Head Neck Surg. 2012;147(4):627-39

Elluru RG, Balakrishnan K, Padua HM. Lymphatic malformations: diagnosis and management. Semin Pediatr Surg. 2014;23(4):178-85

Behr GG, Johnson CM. Vascular anomalies: hemangiomas and beyond--part 2, Slowflow lesions. AJR Am J Roentgenol. 2013;200(2):423-36

Licci S, Puma F, Sbaraglia M, Ascani S. Primary intrathymic lymphangioma. Am J Clin Pathol. 2014;142(5):683-8

Olímpio HeO, Bustorff-Silva J, Oliveira Filho AG, Araujo KC. Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children. Clinics (Sao Paulo). 2014;69(8):505-8

Balakrishnan K, Perkins J. Management of head and neck lymphatic malformations. Facial Plast Surg. 2012;28(6):596-602

Wiegand S, Eivazi B, Zimmermann AP, Sesterhenn AM, Werner JA. Sclerotherapy of lymphangiomas of the head and neck. Head Neck. 2011;33(11):1649-55

Aydin S, Demir MG, Selek A. A giant lymphangioma on the neck. J Craniofac Surg. 2015;26(4):e323-5

Barnacle AM, Theodorou M, Maling SJ, Abou-Rayyah Y. Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience. Br J Ophthalmol. 2016;100(2):204-8

Ardıçlı B, Karnak İ, Çiftçi A, Tanyel FC, Şenocak ME. Sclerotherapy with bleomycin versus surgical excision for extracervical cystic lymphatic malformations in children. Surg Today. 2016;46(1):97-101

Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol. 2007;56(4):541-64

Balakrishnan K, Bauman N, Chun RH, Darrow DH, Grimmer JF, Perkins JA, et al. Standardized outcome and reporting measures in pediatric head and neck lymphatic malformations. Otolaryngol Head Neck Surg. 2015;152(5):948-53

Rozman Z, Thambidorai RR, Zaleha AM, Zakaria Z, Zulfiqar MA. Lymphangioma: Is intralesional bleomycin sclerotherapy effective? Biomed Imaging Interv J. 2011;7(3):e18

Cho BC, Kim JB, Lee JW, Choi KY, Yang JD, Lee SJ, et al. Cervicofacial lymphatic malformations: A retrospective review of 40 cases. Arch Plast Surg. 2016;43(1):10-8

Tanigawa N, Shimomatsuya T, Takahashi K, Inomata Y, Tanaka K, Satomura K, et al. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion. Cancer. 1987;60(4):741-9

Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology. 1997;204(3):651-4

Ramashankar, Prabhakar C, Shah NK, Giraddi G. Lymphatic malformations: A dilemma in diagnosis and management. Contemp Clin Dent. 2014;5(1):119-22

Connell F, Homfray T, Thilaganathan B, Bhide A, Jeffrey I, Hutt R, et al. Congenital vascular malformations: a series of five prenatally diagnosed cases. Am J Med Genet A. 2008;146A(20):2673-80

Lev S, Lev MH. Imaging of cystic lesions. Radiol Clin North Am. 2000;38(5):1013-27

Rebuffini E, Zuccarino L, Grecchi E, Carinci F, Merulla VE. Picibanil (OK-432) in the treatment of head and neck lymphangiomas in children. Dent Res J (Isfahan). 2012;9(Suppl 2):S192-6

De Leacy R, Bageac DV, Manna S, Gershon BS, Kirke D, Shigematsu T, et al. A radiologic grading system for assessing the radiographic outcome of treatment in lymphatic and lymphatic-venous malformations of the head and neck. AJNR Am J Neuroradiol. 2021;42(10):1859-64

Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg. 2011;53(1):150-5

Eliasson JJ, Weiss I, Høgevold HE, Oliver N, Andersen R, Try K, et al. An 8-year population description from a national treatment centre on lymphatic malformations. J Plast Surg Hand Surg. 2016:1-6

Mayouego Kouam J, Epée E, Azria S, Enyama D, Omgbwa Eballe A, Ebana Mvogo C, et al. [Epidemiological, clinical and therapeutic features of pediatric ocular injuries in an eye emergency unit in Île-de-France]. J Fr Ophtalmol. 2015;38(8):743-51

Okazaki T, Iwatani S, Yanai T, Kobayashi H, Kato Y, Marusasa T, et al. Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg. 2007;42(2):386-9

Khunger N. Lymphatic malformations: current status. J Cutan Aesthet Surg. 2010;3(3):137-8.

Kertész Z, Bălă G, Bancu S, Gozar H, Virgil G, Horváth E, et al. [Bleomycin therapy for lymphangioma]. Chirurgia (Bucur). 2011;106(1):103-7

Gorincour G, Paris M, Aschero A, Desvignes C, Bourlière B, Petit P. [Percutaneous treatment of cystic lymphangiomas]. Ann Chir Plast Esthet. 2006;51(4-5):423-8

Mahady K, Thust S, Berkeley R, Stuart S, Barnacle A, Robertson F, et al. Vascular anomalies of the head and neck in children. Quant Imaging Med Surg. 2015;5(6):886-97

Published

2021-03-30

How to Cite

(1)
Vallejo Díaz, J. F. .; Bernal Moreno, M. A. .; Mckinster, C. .; Montejo, G. . Experiencia En El Manejo De Malformaciones linfáticas macroquísticas Con Alcohol Y microquísticas Con Bleomicina. Rev. colomb. radiol. 2021, 32, 5495-5501.

Issue

Section

Research articles
Crossref Cited-by logo
QR Code